Phase 1/2 Study of AGN-241622 in Healthy Participants and Participants With Presbyopia

Stopped early · Phase 1/Phase 2 · Has a placebo group

Conditions studied: Presbyopia

In brief

The objective of this study is to evaluate the safety, tolerability, pharmacokinetics, and efficacy of AGN-241622 ophthalmic solution for the first time in human participants

Key facts

Study ID

NCT04403763

Run by

AbbVie

People needed

80

Starts

2020-07-27

Expected to finish

2022-12-05

Last updated by the study team

2024-02-06

Who can join

Age: 40 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 40 to 65 at the time of study participation.
• Be a nonsmoker and nonuser of nicotine-containing products within the previous 1 year.
• Be able and willing to follow study instructions and complete all required study visits in the opinion of the study doctor.

You may not qualify if…

• History of alcohol or substance abuse within the 5 years prior to study participation.
• Enrollment in another investigational drug or device study within 30 days of study participation.
• Women who are pregnant, nursing, or planning a pregnancy during the study.

Where it is running

• United Medical Research Institute /ID# 234612 — Inglewood, California, United States
• Global Research Foundation /ID# 237353 — Los Angeles, California, United States
• North Valley Eye Medical Group, Inc. /ID# 236686 — Mission Hills, California, United States
• The Eye Research Foundation /ID# 234526 — Newport Beach, California, United States
• Quantum Clinical Trials /ID# 237330 — Miami Beach, Florida, United States
• Kannarr Eye Care /ID# 236718 — Pittsburg, Kansas, United States
• The Eye Care Institute /ID# 234507 — Louisville, Kentucky, United States
• Total Eye Care, PA /ID# 234454 — Memphis, Tennessee, United States
• PPD Clinical Research Unit - Austin /ID# 237644 — Austin, Texas, United States
• Eye associates /ID# 236502 — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.